John Thomas Replay

March 16, 2023

Please note: If the video is not showing on this page - wait a moment for it to appear OR hit refresh.

Why it’s Time to Buy the Dip on Biotech and Health Care

  • A new generation of obesity drugs is creating a $150 billion a year market
  • The safest sector in the market has recently been completely ignored in a post pandemic world
  • We are on the precipice of major breakthrough discoveries at almost every company
  • The first leg of a new bull market in biotech is just ahead of us
  • Many stocks will rise by a multiple from here
  • Learn how to make big money in biotech and save your own life along the way
  • Join the man who made 87% in 2022 and 30% so far in 2023
  • Sign up with the greatest money manager of our generation